Anterior Cruciate Ligament Rupture
LIGAMYS
Ligamys Technique Versus Standard Technique for the Anterior Cruciate Ligament Rupture
1 other identifier
interventional
80
1 country
1
Brief Summary
The assess results of Anterior Cruciate Ligament (ACL) repair with the Ligamys® surgical technique versus standard technique. The aim of the study is to compare (laxity, instability, and safety) these two types of treatment by using a prospective, randomised multicenter analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2016
CompletedFirst Posted
Study publicly available on registry
April 15, 2016
CompletedStudy Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedMarch 15, 2022
June 1, 2021
6.3 years
March 25, 2016
March 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measuring anterior knee laxity with KT 1000 arthrometer
at 12 months
Secondary Outcomes (3)
Tegnér scores
at 12 months
Lysholm scores
at 12 months
IKDC score safety
at 12 months
Study Arms (2)
Ligamys technique
OTHERLigamys technique (device) or standard technique
standard technique
OTHERLigamys technique (device) or standard technique
Interventions
Ligamys technique (device) or standard technique
Eligibility Criteria
You may qualify if:
- Age between 18 to 35 years
- Primary Anterior Cruciate Ligament rupture
- signed patient consent
- surgery 21 days or less after traumatism for Ligamys technique
You may not qualify if:
- infection of the operating site
- previous osseous disease
- pregnant or nursing woman.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Clermont-Ferrand
Clermont-Ferrand, 63003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stéphane DESCAMPS
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2016
First Posted
April 15, 2016
Study Start
September 1, 2016
Primary Completion
December 1, 2022
Study Completion
June 1, 2023
Last Updated
March 15, 2022
Record last verified: 2021-06